| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | See Remarks | Chief Medical Officer
1 company
Reinhart Harald is a See Remarks at ZLAB. Recent filings cover 0 purchases and 34 sales. Those positions are worth an estimated $1.5M at current prices.
Our model assigns Reinhart Harald a strong insider score of 80/100, based on 18 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +38.0%.
Reinhart Harald's largest disclosed position is in ZLAB as See Remarks, worth about $1.5M. The recent filings there lean toward selling, a net 129,446 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2021 | ZLAB Zai Lab Ltd | Chief Medical Officer | Sale+OE | 16,000 | $162.18 | $2,594,800.00 | -100% | -22.6% | -82.8% | |
| May 25, 2021 | ZLAB Zai Lab Ltd | Chief Medical Officer | Sale+OE | 16,000 | $162.02 | $2,592,240.00 | -100% | -8.1% | -79.6% | |
| Apr 21, 2021 | ZLAB Zai Lab Ltd | Chief Medical Officer | Sale+OE | 16,000 | $156.10 | $2,497,520.00 | -100% | +2.6% | -73.2% |